Fuse Medical, Inc. (FZMD)

Fuse Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	18.4	18.64	20.41	21.4	22.9	26.34
Revenue Growth (YoY)	-5.77%	-8.67%	-4.60%	-6.56%	-13.07%	-0.25%
Cost of Revenue	6.03	7.1	8.48	8.69	11.76	13.35
Gross Profit	12.38	11.54	11.94	12.7	11.14	12.99
Selling, General & Admin	12.13	12.22	14.06	13.63	14.45	14.9
Operating Expenses	12.27	12.36	14.13	13.73	14.56	14.95
Operating Income	0.11	-0.82	-2.2	-1.03	-3.42	-1.96
Interest Expense	-0.21	-0.17	-0.08	-0.09	-0.12	-0.13
EBT Excluding Unusual Items	-0.1	-0.99	-2.27	-1.12	-3.54	-2.09
Impairment of Goodwill	-	-	-	-	-0.93	-
Other Unusual Items	4.11	4.11	0.7	-0.29	1.94	5.66
Pretax Income	4	3.12	-1.57	-1.41	-2.54	3.57
Income Tax Expense	0.03	0.02	0.02	0.02	0.78	-0.39
Net Income	3.98	3.1	-1.59	-1.43	-3.32	3.96
Net Income to Common	3.98	3.1	-1.59	-1.43	-3.32	3.96
Net Income Growth	-	-	-	-	-	465.63%
Shares Outstanding (Basic)	70	70	70	70	70	68
Shares Outstanding (Diluted)	82	78	70	70	70	74
Shares Change (YoY)	16.12%	10.72%	0.14%	-	-5.01%	279.62%
EPS (Basic)	0.06	0.04	-0.02	-0.02	-0.05	0.06
EPS (Diluted)	0.05	0.04	-0.02	-0.02	-0.05	0.05
EPS Growth	-	-	-	-	-	25.00%
Free Cash Flow	0.02	0.03	-1.78	0.22	-0.02	2.44
Free Cash Flow Per Share	-	-	-0.03	0.00	-	0.03
Gross Margin	67.25%	61.90%	58.47%	59.37%	48.63%	49.31%
Operating Margin	0.59%	-4.37%	-10.76%	-4.80%	-14.92%	-7.43%
Profit Margin	21.61%	16.62%	-7.78%	-6.69%	-14.48%	15.02%
Free Cash Flow Margin	0.10%	0.19%	-8.71%	1.01%	-0.09%	9.25%
EBITDA	0.24	-0.68	-2.13	-0.92	-3.31	-1.91
EBITDA Margin	1.32%	-3.64%	-10.42%	-4.32%	-14.46%	-7.25%
D&A For EBITDA	0.13	0.14	0.07	0.1	0.11	0.05
EBIT	0.11	-0.82	-2.2	-1.03	-3.42	-1.96
EBIT Margin	0.59%	-4.37%	-10.76%	-4.80%	-14.92%	-7.43%
Effective Tax Rate	0.66%	0.76%	-	-	-	-

Updated Aug 14, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.